News from Demuris

Demuris awarded almost 87,000 grant funding from Technology Strategy Board

7 February 2011

Demuris has secured grant funding of 86,847 from the TSB for a feasibility study in which Demuris, who is the lead (and only) partner, will develop and commercialise novel antibiotic compounds.

The project aims to develop selected compounds from the early stages of discovery through to a point where the compounds can be evaluated for viability of commercialisation and pre-clinical development.

The National Industrial Biotechnology Facility, based in Redcar, will provide the resources to enable the production of sufficient quantities of purified compounds for testing and development purposes.

Further details can be found at the following links:

Technology Strategy Board press release
Technology Strategy Board website

Demuris Limited
The Biosphere, Draymans Way, Newcastle Helix,
Newcastle upon Tyne, NE4 5BX, UK

Tel: +44 (0)191 580 6177


Demuris Limited is registered in England, company number: 06255507

Demuris Limited 2015